Goldiam International (526729) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
20 Oct, 2026Executive summary
Q1 FY25 consolidated total income was Rs16,974.98 lakh and PAT was Rs2,204.28 lakh; revenue from operations was Rs16,580.29 lakh.
Revenue rose 40% YoY to ₹1,697 mn, EBITDA increased 44% to ₹342 mn and PAT rose 27% to ₹220 mn.
Lab-grown diamond jewellery reached 68.4% of B2B export revenue mix, versus 32.7% in Q1 FY24.
Financial highlights
Consolidated revenue from operations was Rs16,580.29 lakh; other income of Rs394.69 lakh brought total income to Rs16,974.98 lakh, versus Rs12,118.40 lakh in Q1 FY24.
EBITDA was ₹342 mn, up 44% YoY; EBITDA margin was 20.1%, up 49 bps YoY.
PAT was Rs2,204.28 lakh versus Rs1,730.05 lakh in Q1 FY24; PAT margin was 13.0% versus 14.3%.
Gross profit rose 46% YoY to ₹581 mn; gross margin expanded 141 bps to 34.2%.
Consolidated profit before tax was Rs3,272.05 lakh versus Rs2,250.24 lakh in Q1 FY24.
Standalone results
Standalone revenue from operations was Rs10,352.17 lakh and PAT was Rs1,201.92 lakh, versus Rs5,831.91 lakh and Rs899.23 lakh, respectively, in Q1 FY24.
Latest events from Goldiam International
- US headwinds pressured revenue, while margins improved and a ₹30 crore Middle-East order expanded reach.526729
Q1 23/24 - Q2 revenue rose 50% as lab-grown jewellery gained share despite margin pressure.526729
Q2 23/24 - Q3 standalone profit rose while consolidated revenue fell versus the prior-year quarter.526729
Q3 23/24 - Lab-grown jewellery reached 49% of FY24 revenue as growth contrasted with lower Q4 audited profit.526729
Q4 23/24 - H1 earnings grew as lab-grown mix expanded, while shipment delays and inventory weighed.526729
Q2 24/25 - Q3 consolidated profit rose as LGD exports expanded; a Rs 1 interim dividend was declared.526729
Q3 24/25 - FY25 earnings grew as lab-grown jewellery reached 82% of Q4 export revenue.526729
Q4 24/25 - Consolidated Q1 profit rose YoY, while standalone profit eased.526729
Q1 25/26 - Record FY26 earnings, 88% lab-grown export mix and a proposed 1-for-3 bonus.526729
Q4 25/26